D. E. Shaw & Co. Inc. Trims Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

D. E. Shaw & Co. Inc. trimmed its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,708 shares of the medical instruments supplier’s stock after selling 405 shares during the quarter. D. E. Shaw & Co. Inc. owned 0.29% of Utah Medical Products worth $597,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in UTMD. SG Americas Securities LLC bought a new stake in Utah Medical Products during the fourth quarter valued at $157,000. R Squared Ltd purchased a new stake in shares of Utah Medical Products in the 4th quarter valued at about $49,000. Golden State Wealth Management LLC bought a new stake in shares of Utah Medical Products during the 4th quarter valued at about $31,000. Allspring Global Investments Holdings LLC grew its holdings in shares of Utah Medical Products by 838.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier’s stock worth $719,000 after purchasing an additional 10,452 shares in the last quarter. Finally, Sanctuary Advisors LLC grew its holdings in shares of Utah Medical Products by 16.1% during the fourth quarter. Sanctuary Advisors LLC now owns 6,961 shares of the medical instruments supplier’s stock worth $426,000 after purchasing an additional 963 shares in the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

Utah Medical Products stock opened at $53.76 on Monday. Utah Medical Products, Inc. has a fifty-two week low of $51.26 and a fifty-two week high of $77.33. The stock has a market cap of $174.61 million, a P/E ratio of 13.61 and a beta of 0.30. The firm’s fifty day moving average price is $54.18 and its 200-day moving average price is $59.25.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The company had revenue of $9.71 million during the quarter.

Utah Medical Products Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 3rd. Investors of record on Monday, June 16th will be given a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Monday, June 16th. Utah Medical Products’s payout ratio is presently 32.28%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.